Clinical Stage I Cutaneous Melanoma AJCC v8
specificStage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0
7
Centers
2
Active Trials
—
Cancer Funding
Top Centers for Clinical Stage I Cutaneous Melanoma AJCC v8(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 73.2 |
| 2 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 73.2 |
| 3 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 50.7 |
| 4 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 50.7 |
| 5 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 50.7 |
| 6 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 50.7 |
| 7 | Boston University Cancer CenterBoston, MA | 50.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →